Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicentre, Randomized, Blind, Parallel-controlled Clinical Trial Evaluating the Efficacy and Safety of Recombinant Collagen Gel for Correcting Moderate to Severe Nasolabial Wrinkles

NCT06854796 is registered in ClinicalTrials.gov with Shaanxi Giant Biotechnology Co., Ltd as lead sponsor.

NCT NCT06854796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06854796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicentre, Randomized, Blind, Parallel-controlled Clinical Trial Evaluating the Efficacy and Safety of Recombinant Collagen Gel for Correcting Moderate to Severe Nasolabial Wrinkles
Lead sponsor
Shaanxi Giant Biotechnology Co., Ltd
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 10, 2025
Completion date
December 31, 2026
Enrollment
244 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasolabial fold wrinkles